课题基金 / 基金详情

Minimizing the role of cryoprotectant toxicity for cryopreservation

Minimizing the role of cryoprotectant toxicity for cryopreservation
最大限度地减少冷冻保护剂毒性对冷冻保存的作用
批准号:
8890272
负责人:
Utkan Demirci
金额:
$5.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2016-06-30

项目摘要

项目成果

Utkan Demirci的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Long-term biopreservation of cells and tissues has a broad impact in multiple fields including tissue engineering, regenerative medicine, stem cells, blood banking, animal strain preservation (biodiversity protection), clinical sample storage, transplantation medicine and in vitro drug testing. Vitrification (ice/crystal-free cryopreservatio) has emerged as a novel approach over traditional slow freezing methods. Although vitrification minimizes mechanical damage due to ice crystal nucleation, it suffers from toxicity due to high concentrations of cryoprotectant agents (CPAs). The current vitrification methods require extremely high levels of CPAs of up to 8.2 M that are cytotoxic and cause osmotic shock. Also, the lengthy manual processing steps of current vitrification methods add to the technical complexity, require highly trained technicians, and result in variations between users. For instance, low CPA-level vitrification has immense potential for the stem cells compared to other methods in preserving their functionality. Recently, we demonstrated that we can achieve vitrification at ultra-rapid freezing and thawing rates with as low as 1.5M CPA concentration. We are adapting this new knowledge to the vital needs of cell cryopreservation at the clinic including discarded anonymous human oocytes. This proposal investigates a new experimental strategy to minimize the CPA concentrations and improve clinical outcomes using novel technologies (i.e., nanoliter droplet vitrification). These steps are facilitated by theoretical understanding o the underlying mechanisms governing vitrification. The expected outcome of this study is a closed-system platform technology with broad applications to human cell (e.g., hepatocytes, oocytes, sperm, stem cells), tissues (e.g., blood), micro-tissues (e.g., embryoid bodies, islets) covering areas of reproductive medicine, tissue engineering and regenerative medicine as well as to wild life preservation. These studies can also significantly impact the care of infertile couples and facilitate fertility preservation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NOVEL EXOSOME BIOMARKERS OF IRON PATHOLOGY IN AD
  • 批准号:
    10223789
  • 项目类别:
  • 资助金额:
    $43.3万
  • 财政年份:
    2021
  • 负责人:
    Utkan Demirci
  • 依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
  • 批准号:
    10462468
  • 项目类别:
  • 资助金额:
    $23.67万
  • 财政年份:
    2017
  • 负责人:
    Utkan Demirci
  • 依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
  • 批准号:
    10713237
  • 项目类别:
  • 资助金额:
    $41.86万
  • 财政年份:
    2017
  • 负责人:
    Utkan Demirci
  • 依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
  • 批准号:
    9358372
  • 项目类别:
  • 资助金额:
    $25.9万
  • 财政年份:
    2017
  • 负责人:
    Utkan Demirci
  • 依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
  • 批准号:
    82371070
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵培泉
  • 依托单位: